![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 35, 24559-24566, August 27, 1999
,
, and
**
From the
Department of Diabetes, The Medical School,
University of Newcastle upon Tyne,
Newcastle upon Tyne NE2 4HH, United Kingdom,
§ Department of Medicine, University of Toronto,
Toronto, Ontario M5G 2C4, Canada, ¶ Department of Biochemistry,
University of Minnesota Medical School, Minneapolis, Minnesota 55455, and
Gifford Laboratories for Diabetes Research, Departments of
Biochemistry and Internal Medicine, University of Texas Southwestern
Medical Center, Dallas, Texas 75235
| |
ABSTRACT |
|---|
|
|
|---|
In hepatocytes glucokinase (GK) and
glucose-6-phosphatase (Glc-6-Pase)1 have converse effects
on glucose 6-phosphate (and fructose 6-phosphate) levels. To establish
whether hexose 6-phosphate regulates GK binding to its regulatory
protein, we determined the effects of Glc-6-Pase overexpression on
glucose metabolism and GK compartmentation. Glc-6-Pase overexpression
(4-fold) decreased glucose 6-phosphate levels by 50% and inhibited
glycogen synthesis and glycolysis with a greater negative control
coefficient on glycogen synthesis than on glycolysis, but it did not
affect the response coefficients of glycogen synthesis or glycolysis to
glucose, and it did not increase the control coefficient of GK or cause
dissociation of GK from its regulatory protein, indicating that in
hepatocytes fructose 6-phosphate does not regulate GK translocation by
feedback inhibition. GK overexpression increases glycolysis and
glycogen synthesis with a greater control coefficient on glycogen
synthesis than on glycolysis. On the basis of the similar relative
control coefficients of GK and Glc-6-Pase on glycogen synthesis
compared with glycolysis, and the lack of effect of Glc-6-Pase
overexpression on GK translocation or the control coefficient of GK, it
is concluded that the main regulatory function of Glc-6-Pase is to
buffer the glucose 6-phosphate concentration. This is consistent with
recent findings that hyperglycemia stimulates Glc-6-Pase gene transcription.
The relative activities of hepatic
glucokinase and glucose-6-phosphatase, which catalyze the first and
last steps in glucose utilization and production, respectively, are
thought to have a major role in regulating blood glucose homeostasis
(1-3). The activities of these two enzymes change in a converse manner
during fasting and refeeding or during insulin deficiency and insulin treatment. Fasting and insulin deficiency are associated with inhibition of glucokinase transcription and with a gradual decline in
total glucokinase activity, whereas refeeding or insulin treatment restores glucokinase activity by induction of glucokinase transcription (4, 5). Conversely, the transcription of glucose-6-phosphatase is
negatively regulated by insulin, and the activity of
glucose-6-phosphatase is markedly increased in fasted or
insulin-deficient diabetic states (6, 7). In addition to changes in
total enzyme concentration by regulation of gene transcription,
glucokinase activity is also regulated acutely by a translocation
mechanism (8-10). This involves the sequestration of glucokinase in an
inactive state in the nucleus (10) bound to a 68-kDa regulatory protein
at low concentrations of extracellular glucose (8, 9). A rise in
extracellular glucose or low concentrations of fructose or sorbitol
cause the rapid dissociation of glucokinase from its regulatory protein and the translocation of the enzyme to the cytoplasm. This
translocation mechanism results in a large increase in glucokinase
activity in the cytoplasm within minutes of a rise in extracellular
glucose concentration (8, 10). The binding properties of glucokinase to
its 68-kDa regulatory protein have been extensively characterized from
studies on the purified proteins (11-15). Binding of glucokinase to
the regulatory protein is enhanced by fructose 6-phosphate, and this
effect is antagonized by fructose 1-phosphate. Both ligands bind to the
same site on the regulatory protein and alter its affinity for
glucokinase. It has been proposed that the rise in fructose 6-phosphate
in hepatocytes during active glycogenolysis and gluconeogenesis causes
increased binding of glucokinase to the regulatory protein and
decreased glucose phosphorylation (15-17), whereas the increase in
fructose 1-phosphate that results from metabolism of fructose or
sorbitol causes dissociation of glucokinase from the regulatory protein
(9, 18). Although the role of fructose 1-phosphate in explaining the
translocation of glucokinase by fructose and sorbitol is now firmly
established (18), the role of changes in fructose 6-phosphate in
regulating the binding of glucokinase to its regulatory protein in the
intact cell remains a contentious issue, with arguments both for
(15-17) and against (19) a physiological role for changes in fructose
6-phosphate in the intact cell. Adenovirus-mediated
glucose-6-phosphatase overexpression markedly suppresses the hepatocyte
glucose 6-phosphate content (20) and thereby fructose 6-phosphate which
is in equilibrium with glucose 6-phosphate (16) and thus provides a
powerful tool to unequivocally test the physiological role of changes
in hexose 6-phosphate in the intact cell.
In order to evaluate the regulatory function of glucose-6-phosphatase
in the hepatocyte, this study had three aims. The first was to
determine the role of changes in hepatocyte hexose 6-phosphate content
in regulating glucokinase translocation. The second was to determine
the control strengths (control coefficients) of glucose-6-phosphatase and glucokinase on glycolysis and glycogen synthesis. The third was to
determine whether glucose-6-phosphatase overexpression alters the
control strength of glucokinase on glycolysis or glycogen synthesis or
the response coefficients of these pathways to glucose in the
hepatocyte. The results support a hypothesis that the primary regulatory function of glucose-6-phosphatase in the hepatocyte is to
buffer the glucose 6-phosphate concentration. This hypothesis is
consistent with recent apparently paradoxical findings on
glucose-6-phosphatase activity in experimental and pathological states.
Materials--
Glucose dehydrogenase (Bacillus) was
from Calbiochem. Glucose dehydrogenase (Thermoplasma) and
all other enzymes were from Sigma. [U-14C]Glucose,
[2-3H]glucose, and [3-3H]glucose were from
NEN Life Science Products. Sources of other reagents were as described
previously (21).
Preparation of Recombinant Adenoviruses--
Recombinant
adenoviruses containing the cDNA encoding either the catalytic
subunit of rat glucose-6-phosphatase (AdCMV-G6P), Escherichia
coli Hepatocyte Isolation and Culture--
Hepatocytes were isolated
by collagenase perfusion of the liver of male Wistar rats (body weight
180-250 g) obtained from Bantin & Kingman (Hull, UK) and fed ad
libitum (25). The hepatocytes were suspended in minimum essential
medium supplemented with 7% (v/v) neonatal calf serum and inoculated
in 24-well plates at a density of 4 × 104
cells/cm2. After cell attachment (2-3 h), the medium was
replaced with serum-free medium containing the adenoviruses (21).
Treatment of the Hepatocytes with Adenoviruses--
After
amplification in 293 cells AdCMV-G6Pase and AdCMV-
AdCMV-GKL was amplified in 293 cells, and aliquots of medium lysate
were used. For experiments determining the control strength of
glucose-6-phosphatase or glucokinase on glycogen synthesis or
glycolysis, 5 titers of adenovirus at progressive 2-fold dilutions were
used. For experiments examining a range of substrate concentrations, two adenovirus titers were used that resulted in enzyme overexpression of 2.0 ± 0.1- or 4.6 ± 0.5-fold, (means ± S.E.,
n = 5) above endogenous levels. After cell attachment
the hepatocyte monolayers were incubated for 90 min in serum-free
minimum essential medium containing the adenovirus. The medium was then
replaced with serum-free minimum essential medium containing 10 nM dexamethasone, and the hepatocyte monolayers were
cultured for 16 h. Incubations for metabolic studies were in fresh
medium containing 2 µM cycloheximide (21).
Metabolic Studies--
Incubations were for 3 h in minimum
essential medium containing the substrates indicated and either
[U-14C]glucose (2 µCi/ml) for determination of glycogen
synthesis or [2-3H]glucose or [3-3H]glucose
(2 µCi/ml) for determination of glucose phosphorylation or
glycolysis, respectively. On termination of the incubations, the medium
from experiments with [3H]glucose was collected into 0.1 M HCl for determination of 3H2O
(see Ref. 19). Results are expressed as nanomoles of glucose detritiated for 3 h per mg of cell protein which was determined by
an automated Lowry method (26). Glucose-6-phosphatase,
Enzyme Activity Determination--
For determination of
glucose-6-phosphatase and Determination of Control Coefficients--
The control strengths
or control coefficients (CEJ) of
glucose-6-phosphatase or glucokinase were each determined for glycogen
synthesis or glycolysis. The control coefficient is defined as the
fractional change (+ increase,
In experiments involving one or two levels of enzyme overexpression
over a range of substrate conditions, control coefficients were
determined by the Taylor expansion of Equation 1 (see Equation 2) for
levels of enzyme overexpression of
The response coefficient of glycogen synthesis or glycolysis to
extracellular glucose was determined from the slopes of plots of log
flux against log glucose concentration (31) in cells treated with
AdCMV-G6Pase or AdCMV- Expression of Results--
Results are expressed as means ± S.E. for the number of cell cultures indicated. Control or response
coefficients were determined from individual experiments (linear
regression of double logarithmic plots or Taylor expansion for a single
enzyme overexpression), and means and S.E. were determined. Statistical
analysis was by the Student's paired t test.
Effects of Graded Glucose-6-phosphatase Overexpression on Glucose
Metabolism--
The effects of glucose-6-phosphatase overexpression on
glucose metabolism were initially determined in incubations containing 25 mM glucose. Hepatocytes were treated with 5 titers of
AdCMV-G6Pase at sequential 2-fold dilutions such that the highest titer
resulted in approximately 4-fold overexpression of
glucose-6-phosphatase activity above endogenous activity. Control
incubations were either untreated or treated with equivalent titers of
AdCMV-
Glucose-6-phosphatase overexpression inhibited glycolysis, determined
from the detritiation of [3-3H]glucose, by up to 15% and
glycogen synthesis by 50% at 4-fold glucose-6-phosphatase
overexpression (Fig. 2). Treatment with AdCMV-
The control coefficient of glucose-6-phosphatase on glycolysis or
glycogen synthesis was determined from the slope of double logarithmic
plots of metabolic flux (J) against glucose-6-phosphatase activity (e). Representative plots are shown as
insets in Fig. 2. The control coefficient of
glucose-6-phosphatase on both glycogen synthesis and glycolysis is
negative since enzyme overexpression inhibits metabolic flux. The
control coefficient on glycogen synthesis (CG6PaseJGS = Glucose-6-phosphatase Overexpression Does Not Affect Glucokinase
Translocation in Response to Either Glucose or Sorbitol--
Glucose
and precursors of fructose 1-phosphate cause translocation of
glucokinase from a bound state in the nucleus (10) to the cytoplasm
which can be determined by a digitonin-permeabilization assay (8, 21).
Changes in the hepatocyte hexose 6-phosphate content are thought to
have a physiological role in regulating the binding of glucokinase to
its regulatory protein (15-17). Since glucose-6-phosphatase
overexpression lowers the hepatocyte glucose 6-phosphate content by
50% (Fig. 1), we determined whether this lowering of glucose
6-phosphate and fructose 6-phosphate (16) interferes with glucokinase
translocation in response to varying glucose concentration or to
sorbitol, a precursor of fructose 1-phosphate. Overexpression of
AdCMV-G6Pase by more than 3-fold did not affect glucokinase
translocation in response to either glucose or sorbitol (Fig.
3, A and B), and it
also did not affect the detritiation of [2-3H]glucose at
any substrate concentration (Fig. 3, C and
D).
Effects of Glucose-6-phosphatase Overexpression on Glycolysis and
Glycogen Synthesis in Different Substrate Conditions--
In
experimental conditions associated with varying degrees of glucokinase
translocation by glucose or sorbitol, glucose-6-phosphatase overexpression (>3-fold) significantly inhibited glycolysis at all
substrate concentrations and glycogen synthesis at all concentrations above 10 mM glucose or in the presence of sorbitol (Fig.
4).
The control coefficients of glucose-6-phosphatase on glycogen synthesis
or glycolysis were determined by the Taylor expansion for the substrate
conditions in Fig. 4, for experiments where the increment of
glucose-6-phosphatase overexpression was
For the incubations at varying glucose concentrations the control
coefficient for glycogen synthesis
(CG6PaseJGS) was
between Effects of Glucose-6-phosphatase Overexpression on the Response
Coefficients of Glycolysis and Glycogen Synthesis to Glucose--
To
evaluate whether glucose-6-phosphatase overexpression alters the
response of glucose metabolism to glucose concentration through changes
in glucokinase activity, we determined the response coefficients of
glycolysis and glycogen synthesis to glucose for AdCMV-G6Pase-treated
and AdCMV- The Control Coefficient of Glucokinase on Glycolysis Is Lower Than
on Glycogen Synthesis--
We have shown previously that glucokinase
has a very high control coefficient on glycogen synthesis (21). To
investigate the underlying mechanism for the greater negative control
coefficient of glucose-6-phosphatase on glycogen synthesis compared
with glycolysis, we determined the control coefficient of glucokinase
on glycolysis and glycogen synthesis at varying glucose concentrations
(5-35 mM) in hepatocytes treated with 5 titers of
AdCMV-GKL to achieve varying degrees of glucokinase overexpression.
Control coefficients were determined from the initial slope of plots of
log flux versus log total glucokinase activity. A
representative experiment is shown in Fig.
5, and the results of replicate
experiments plotted individually are summarized in Table
II. The control coefficient of
glucokinase on both glycolysis and glycogen synthesis decreased with
increasing glucose concentration, and in these substrate conditions the
control coefficient for glycogen synthesis was greater than for
glycolysis (Table II).
Effects of Glucose-6-phosphatase Overexpression on the Control
Coefficient of Glucokinase on Glycogen Synthesis--
Since
glucokinase and glucose-6-phosphatase have positive and negative
control coefficients, respectively, on glycogen synthesis and
glycolysis, we determined whether glucose-6-phosphatase overexpression alters the control coefficient of endogenous glucokinase. This was
determined from the experiments with varying sorbitol concentration (Fig. 4D) from double logarithmic plots of glycogen
synthesis against free glucokinase activity (see "Experimental
Procedures"). Overexpression of glucose-6-phosphatase by 2-fold above
endogenous levels inhibited glycogen synthesis but did not affect the
control coefficient (Table III and Fig.
6), indicating that the sensitivity of
glycogen synthesis to an incremental increase in glucokinase activity
is unaffected. However, at higher levels of glucose-6-phosphatase overexpression (4.6 ± 0.5-fold above endogenous levels), the
control coefficient on glycogen synthesis was decreased by 35%,
whereas that on glycolysis was unaffected (Table III).
Glucokinase (hexokinase IV) differs from the other hexokinase
isoenzymes (I-III) in that it is not inhibited by physiological concentrations of glucose 6-phosphate, the product of the reaction (4).
Since binding of purified glucokinase to the regulatory (inhibitory)
protein is enhanced by fructose 6-phosphate (11, 13), it has been
proposed that fructose 6-phosphate is a substitute for end product
inhibition by glucose 6-phosphate because fructose 6-phosphate and
glucose 6-phosphate are maintained in equilibrium by
phosphoglucoisomerase (19). This hypothesis was tested using mannitol
which is metabolized by hepatocytes to mannitol 1-phosphate (19).
Mannitol was shown to inhibit glucose metabolism and glucokinase translocation. Since mannitol 1-phosphate can act as an analogue of
fructose 6-phosphate in promoting binding of glucokinase to the
regulatory protein (14), these findings appeared to support the
hypothesis that binding of glucokinase to the regulatory protein in
intact hepatocytes is regulated by analogues of fructose 6-phosphate (19). However, the possibility that the inhibitory effect of mannitol
on detritiation of glucose was due to other mechanisms could not be
rigorously excluded since mannitol 1-phosphate is a potent inhibitor of
phosphoglucoisomerase (19). Direct evidence in support of regulation of
glucokinase translocation in intact hepatocytes by changes in fructose
6-phosphate/glucose 6-phosphate is still lacking.
The first aim of this study was to determine whether lowering the
hexose 6-phosphate content of hepatocytes by glucose-6-phosphatase overexpression causes dissociation of glucokinase from its regulatory protein as assessed from the distribution of glucokinase between free
and bound states and from the response coefficients of glycogen synthesis and glycolysis to glucose. If changes in the hepatocyte hexose 6-phosphate content have a physiological role in regulating the
binding of glucokinase to its regulatory protein, then lowering of the
hexose 6-phosphate content with glucose-6-phosphatase would be expected
to potentiate the translocation of glucokinase in response to glucose
or sorbitol and to increase the response coefficient of glycolysis and
glycogen synthesis to glucose. Our results demonstrate that lowering of
the hepatocyte hexose 6-phosphate content by glucose-6-phosphatase
overexpression does not affect glucokinase translocation at any
concentration of glucose (5-35 mM) or sorbitol, as
determined from the free glucokinase activity that is a measure of the
cytoplasmic enzyme (9, 10). Consistent with the unchanged cytoplasmic
glucokinase activity, no increase in the response coefficients of
glycogen synthesis or glycolysis to glucose was noted. The glucose
6-phosphate content of hepatocytes increases more than 2-fold between 5 and 25 mM glucose (19, 20), and it is markedly decreased by
glucose-6-phosphatase overexpression (20). The translocation of
glucokinase by increasing glucose concentration (despite the increase
in glucose 6-phosphate/fructose 6-phosphate levels) is explained by the
effect of glucose on dissociation of glucokinase from the regulatory
protein (19). The present finding that lowering the hexose 6-phosphate
concentration by glucose-6-phosphatase overexpression (over a range of
substrate concentrations) does not cause dissociation of glucokinase
from its regulatory protein indicates that physiological changes in hexose 6-phosphate do not regulate glucokinase binding to the regulatory protein by feedback inhibition. It seems likely, therefore, that the regulatory protein is saturated with fructose 6-phosphate under most conditions. These findings support the conclusion that the
two main functions of the regulatory protein are for feed-forward activation of glucokinase by glucose and for stimulation of glucose metabolism by precursors of fructose 1-phosphate but not for feedback inhibition by glucose 6-phosphate/fructose 6-phosphate. A major function of the liver is the maintenance of blood glucose homeostasis. Regulation of glucokinase translocation by feed-forward activation by
glucose without feedback inhibition by hexose 6-phosphate is consistent
with such a function.
The second aim of this study was to gain insight into the regulatory
function of glucose-6-phosphatase in hepatocytes. The recognition that
the rate of glucose phosphorylation in hepatocytes, estimated from the
detritiation of [2-3H]glucose, exceeds the rate of
glucose metabolism has led to several hypotheses on the possible
regulatory function(s) of the glucose/glucose 6-phosphate cycle (32,
33). Suggested functions of substrate cycles in general include the
following: increased sensitivity of regulation; control of the
direction of flux at metabolic branchpoints; buffering of metabolite
concentrations; balancing ATP production and utilization by
regenerating ADP and thermogenesis (31, 33). To investigate the
regulatory function of glucose-6-phosphatase in the hepatocyte, we used
metabolic control analysis to determine the control strength of
glucose-6-phosphatase on glycogen synthesis and glycolysis, and we
determined whether glucose-6-phosphatase overexpression alters the
control strength of glucokinase. Metabolic control analysis is a very
useful analytical approach to probe the regulatory mechanisms that
operate in the intact cell. Kacser and Burns (29) showed that the rate
of flux through a metabolic pathway approximates a hyperbolic function
of the activity (or concentration) of constituent enzymes of the
pathway. The control coefficient (control strength) of an enzyme is a
measure of the sensitivity of pathway flux to changes in the
concentration (activity) of the enzyme and can be determined either
from the slope of the curve of pathway flux against enzyme
concentration multiplied by the scaling factor or from the slope of a
double logarithmic plot of flux against enzyme concentration (29, 30).
Since the relation between flux and enzyme concentration is hyperbolic, the control coefficient of enzymes generally decreases with increasing enzyme concentration. We showed previously (21) that glucokinase has a
very high control strength on glycogen synthesis, and this is dependent
on the glucose concentration. We proposed that the translocation of
glucokinase between the nucleus and the cytoplasm is a major
contributing factor to the high control strength and accounts for the
glucose dependence (28). At low glucose concentration when glucokinase
is sequestered in an inactive state in the nucleus and the activity of
cytoplasmic activity is minimal, a small increase in total glucokinase
activity by adenovirus-mediated overexpression is associated with a
larger fractional increase in cytoplasmic activity (compared with total
activity) and accordingly with a large fractional increase in glycogen
synthesis (21, 28). At higher glucose concentrations when glucokinase
is equally distributed between the nucleus and the cytoplasm (or
present predominantly in the cytoplasm), an increase in total enzyme
activity by overexpression is associated with a similar fractional
increase in cytoplasmic activity and, accordingly, with a lower
fractional stimulation of glycogen synthesis than at low glucose
concentration (28).
The present results show first that glucose-6-phosphatase
overexpression inhibits glycogen synthesis and glycolysis from glucose without affecting glucokinase translocation. Second, they show that
both glucokinase and glucose-6-phosphatase have a greater control
coefficient (positive and negative, respectively) on glycogen synthesis
than on glycolysis. Third, they show that the control coefficient of
glucokinase but not that of glucose-6-phosphatase is dependent on
glucose concentration. Fourth, they show that the control coefficient
of glucokinase on glycogen synthesis is greater than the control
coefficient of glucose-6-phosphatase. Finally, glucose-6-phosphatase
overexpression does not increase the control coefficient of
glucokinase. The latter finding does not support a regulatory role for
glucose-6-phosphatase in increasing the sensitivity of regulation of
glucose metabolism. The findings that the control coefficient of
glucokinase but not that of glucose-6-phosphatase is dependent on
glucose concentration and that glucokinase has a greater control
coefficient than glucose-6-phosphatase, particularly at low glucose,
are consistent with our previous hypothesis that the compartmentation
of glucokinase in the hepatocyte is a major contributing factor to both
the high control strength at low glucose concentration and to the
glucose dependence of the control strength (21, 28).
Glucokinase and glucose-6-phosphatase have converse effects on the
hepatocyte glucose 6-phosphate content (20, 34). The present study
shows converse effects on glycolysis and glycogen synthesis with both
glucokinase and glucose-6-phosphatase having a greater control strength
on glycogen synthesis than on glycolysis. Based on these findings that
overexpression of glucose-6-phosphatase has no effect on glucokinase
translocation and that it also does not increase the control strength
of glucokinase, we propose that the main regulatory function of
glucose-6-phosphatase is to buffer the glucose 6-phosphate
concentration in the hepatocyte. It is noteworthy that in the intact
cell the buffering role of the glucose-6-phosphatase system would be
determined not only by changes in expression of the catalytic subunit
of glucose-6-phosphatase but also by the glucose 6-phosphate
transporter which determines the kinetics of entry of glucose
6-phosphate into the endoplasmic reticulum.
The role of glucose 6-phosphate in regulating both glycolysis and
glycogen synthesis in the hepatocyte is well established. Glucose
6-phosphate regulates glycolysis by increasing the concentration of
fructose 2,6-bisphosphate, a potent allosteric activator of phosphofructokinase-1 (35, 36). Substrate-induced translocation of
glucokinase is associated with a marked increase in glucose 6-phosphate
and fructose 2,6-bisphosphate in hepatocytes, and the latter explains
the stimulation of glycolysis by sorbitol (19, 28). Glucose 6-phosphate
increases glycogen synthesis both by acting as an allosteric activator
of glycogen synthase and by increasing the dephosphorylation state of
glycogen synthase by rendering the enzyme a better substrate for
synthase phosphatase (37). The latter effect has been established from
studies demonstrating a correlation between the activation state of
glycogen synthase and glucose 6-phosphate in hepatocytes overexpressing
glucokinase (34).
The present hypothesis that the primary regulatory function of
glucose-6-phosphatase is to buffer the concentration of glucose 6-phosphate, a pivotal regulator of glycogen synthesis and glycolysis, is consistent with various recent apparently paradoxical findings on
glucose-6-phosphatase. First, studies both in vivo (38) and in vitro on isolated hepatocytes or hepatoma cell lines (6, 39, 40) have shown that high glucose concentrations induce glucose-6-phosphatase gene transcription. If the primary regulatory role of glucose-6-phosphatase in the liver cell were to control gluconeogenesis then induction of transcription by glucose is unexpected. Accordingly, the transcription of hepatic
phosphoenolpyruvate carboxykinase, which unlike glucose-6-phosphatase
has an exclusive role in gluconeogenesis, is repressed by glucose
metabolism (41). However, if the primary regulatory function of
glucose-6-phosphatase were to buffer the glucose 6-phosphate
concentration then induction by hyperglycemia is not a pathological
consequence of uncontrolled diabetes (38) but a compensatory mechanism.
We have shown recently that glucose-6-phosphatase overexpression
in vivo increases blood glucose levels in the fed state and
when fasted rats are challenged with an oral glucose tolerance test but
paradoxically not in the fasted state (42). This finding can also be
explained by the primary regulatory role of glucose-6-phosphatase in
buffering glucose 6-phosphate levels in the absorptive state when
glucokinase is in the cytoplasmic compartment. Glycogenolysis and
gluconeogenesis are the two sources of glucose 6-phosphate for hepatic
glucose production during fasting. The rate of glycogenolysis is
determined by the activity of phosphorylase. The regulation of
gluconeogenesis has been extensively studied by Groen and co-workers
(43) who determined the control coefficients of the gluconeogenic
enzymes in hepatocytes from starved rats and demonstrated the
importance of regulation at pyruvate kinase and pyruvate carboxylase.
The flux control coefficient of glucose-6-phosphatase on
gluconeogenesis was found to be remarkably low (~0.02), and the
glucose 6-phosphate concentration was far below the
Km (43). Accordingly the "flux-generating steps"
of hepatic glucose production are phosphorylase and pyruvate metabolism
at the phosphoenolpyruvate branchpoint. This would explain why
glucose-6-phosphatase overexpression does not elevate fasting glycemia
(42). It does, however, markedly elevate glucose levels in the fed
state and particularly the response to an oral glucose tolerance test
(42), consistent with the present hypothesis of a role of
glucose-6-phosphatase in buffering the glucose 6-phosphate
concentration of the hepatocyte.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase (AdCMV-
Gal), or rat liver
glucokinase (AdCMV-GKL) under the control of the cytomegalovirus
promoter were prepared as described previously (22-24).
Gal were purified
by CsCl density gradient centrifugation (24) and diluted to the same
absorbance (260 nm) and stored at
70 °C. Dilutions of the
AdCMV-G6Pase stock were determined that resulted in
glucose-6-phosphatase overexpression between 4- and 6-fold above
endogenous activity (25 ± 2 milliunits/mg, n = 11). For all experiments with AdCMV-G6Pase, controls with equivalent
titers of AdCMV-
Gal (based on the absorbance at 260 nm) were used.
The highest AdCMV-
Gal titer resulted in expression of 150-200
milliunits of
-galactosidase/mg of protein.
-galactosidase and glucokinase activities, were determined on
termination of the incubations with [3H]glucose as
described below. For determination of glycogen synthesis hepatocyte
monolayers were washed 3 times with 150 mM NaCl and extracted in 0.1 M NaOH. Extracts were deproteinized with
trichloroacetic acid (10%, w/v) containing glycogen carrier, and
radioactivity incorporated into glycogen was determined as in Ref. 25.
Glycogen synthesis is expressed as nanomoles of glucose incorporated
into glycogen for 3 h per mg of cell protein. For determination of glucose 6-phosphate hepatocyte monolayers were washed once in 150 mM NaCl and snap-frozen in liquid N2. They were
then extracted in 3% (w/v) HClO4, and glucose 6-phosphate
was determined in the neutralized perchlorate extracts (19). Loss of
3H from [2-3H]glucose in hepatocytes is
generally assumed to occur after phosphorylation of glucose to glucose
6-phosphate and equilibration of glucose 6-phosphate with fructose
6-phosphate via phosphoglucoisomerase. However, an exchange reaction
between glucose and glucose 6-phosphate (catalyzed by
glucose-6-phosphatase) also contributes to loss of 2-tritium from
glucose (16). This exchange reaction was estimated by incubation of
hepatocyte monolayers in medium containing 130 mM KCl, 3 mM HEPES, 20 mM KHCO3, 0.5 mM EDTA, 0.05 mg/ml digitonin, 25 mM
[2-3H]glucose, 0.5 mM glucose 6-phosphate, pH
7.2, for 60 min. On termination of the incubation medium was collected
in 0.1 M HCl for determination of
3H2O (19). Rates of formation of
3H2O were linear with time, and there was no
loss of glucose-6-phosphatase activity from the permeabilized cells
during the incubation.
-galactosidase (total activity), the
hepatocyte monolayers were washed 3 times with 150 mM NaCl
to completely remove medium glucose. They were then extracted by brief
sonication (<5 s) in buffer containing 150 mM KCl, 3 mM HEPES, 2 mM dithiothreitol, 0.05 mg/ml
digitonin, pH 7.2, and assayed immediately. For glucose-6-phosphatase
the assay based on Ref. 27 contained 27 mM glucose
6-phosphate, 50 mM imidazole, 1 mM EDTA, 2.5 mM NAD, 0.6 units/ml mutarotase, 6 units/ml glucose
dehydrogenase (Bacillus), pH 6.5. For
-galactosidase the
assay contained 34 mM lactose, 80 mM potassium
phosphate, 1 mM MgSO4, 2 mM NADP,
0.6 units/ml mutarotase, and 12 units/ml glucose dehydrogenase
(Thermoplasma), pH 7.0. Glucokinase translocation was
determined from the distribution of activity between free and bound
fractions during permeabilization of the hepatocyte monolayers with
digitonin in the presence of 5 mM Mg2+ as in
Ref. 21, and the free glucokinase activity representing the cytoplasmic
fraction (28) is expressed as a percentage of total activity (21). The
total activity of glucokinase in this study was 13.7 ± 1.5 (n = 11) milliunits/mg protein.
decrease) in metabolic flux
(J) that results from a fractional change in enzyme activity (e) as shown in Equation 1,
where J is the flux through the pathway, and
e is the activity of the enzyme, and can be determined from
the slope of log J (glycolysis or glycogen synthesis)
against log e (glucokinase or glucose-6-phosphatase) (29,
30). Unless indicated otherwise, control coefficients were determined
from the initial slope of double logarithmic plots of flux
(J) against total enzyme activity (e).
(Eq. 1)
2-fold above endogenous activity.
For determination of the effects of glucose-6-phosphatase
overexpression on the control coefficient of glucokinase on glycogen synthesis or glycolysis, hepatocytes treated with either AdCMV-G6Pase (2 titers that resulted in enzyme overexpression of either 2- or
4.6-fold) or with equivalent titers of AdCMV-
(Eq. 2)
Gal were incubated with
varying concentrations of sorbitol (5-200 µM) to induce
varying degrees of translocation of glucokinase. The control
coefficient of glucokinase was determined from the slope of plots of
log flux against log free glucokinase activity. The validity of this
method rests on two assumptions as follows: the effect of sorbitol on glycogen synthesis or glycolysis is exclusively due to glucokinase translocation, and the free (unbound) glucokinase activity is a measure
of the active glucokinase in the cytoplasm (28).
Gal. The response coefficient, RGlcJ, is a measure of
the sensitivity of flux to glucose (see Equation 3).
The response coefficient is a function of the control
coefficient (CGKJGly)
and the elasticity (
(Eq. 3)
) of the enzyme with respect to the parameter (glucose) and thus provides a measure of whether a metabolic
perturbation (e.g. glucose-6-phosphatase overexpression)
alters the sensitivity of glucokinase to glucose (its elasticity) (see
Equation 4).
The elasticity of glucokinase (GK) with respect to glucose is a
function of the intrinsic kinetics of glucokinase and of the binding of
glucokinase to its regulatory protein. Thus the determination of the
response coefficient is an additional approach to determine whether
glucose-6-phosphatase overexpression alters binding of glucokinase to
its regulatory protein (without measurement of glucokinase compartmentation).
(Eq. 4)
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Gal (based on absorbance of purified adenovirus).
Glucose-6-phosphatase overexpression resulted in a
dose-dependent decrease in the hepatocyte content of
glucose 6-phosphate of about 50% at 4-fold level of
glucose-6-phosphatase overexpression, whereas treatment with
AdCMV-
Gal had no effect (Fig.
1A).
Glucose-6-phosphatase overexpression or treatment with AdCMV-
Gal had no effect on detritiation of
[2-3H]glucose (Fig. 1B). Loss of 2-tritium as
water occurs in the reaction catalyzed by phosphoglucoisomerase and is
a measure of the rate of glucose phosphorylation to glucose 6-phosphate
although it is an underestimate because loss of 3H is
incomplete (32). An exchange reaction between glucose 6-phosphate and
glucose (catalyzed by glucose-6-phosphatase) also contributes to the
loss of 2-tritium from glucose (16). In hepatocytes expressing endogenous glucose-6-phosphatase (treated with AdCMV-
Gal), loss of
2-tritium from glucose by the exchange reaction determined at 25 mM glucose and 0.5 mM glucose 6-phosphate in
permeabilized cells (see "Experimental Procedures") accounted for
1.7% of the rate of detritiation in intact cells, and in hepatocytes
overexpressing glucose-6-phosphatase by 5-fold above endogenous
activity, the exchange reaction accounted for 7.9% of the rate of
detritiation in intact cells. Thus the exchange reaction appears to
account for only a small proportion of the rate of detritiation of
[2-3H]glucose.

View larger version (11K):
[in a new window]
Fig. 1.
Glucose-6-phosphatase overexpression lowers
the hepatocyte glucose 6-phosphate content but does not affect glucose
phosphorylation. Hepatocytes were either untreated or treated with
5 titers of AdCMV-G6Pase (G6Pase,
) or AdCMV-
Gal
(
-Gal,
). After 16 h culture the hepatocytes were
incubated in medium containing 25 mM glucose without
(A) or with (B) [2-3H]glucose.
A, hepatocyte glucose 6-phosphate content (nmol/mg protein).
B, detritiation of [2-3H]glucose (nmol/3 h per
mg of protein). Results are plotted against the respective activities
of glucose-6-phosphatase for the untreated and AdCMV-G6Pase-treated
cells. Standard errors for glucose-6-phosphatase activity were <15%
of the means (x axis, not shown). The cells that were treated with
AdCMV-
Gal had the same glucose-6-phosphatase activity as untreated
cells (21.5 ± 2.4 milliunits/mg) but are plotted on the
x axis against the corresponding titers of AdCMV-G6Pase.
Values are means ± S.E. for 4 (A) or 6 (B)
cultures. * p < 0.05; ** p < 0.005 AdCMV-G6Pase versus corresponding titer of
AdCMV-
Gal.
Gal had no effect on glycolysis but caused a small inhibition of glycogen synthesis (15%) at the highest viral titers (150-200 milliunits/mg
-galactosidase). Throughout this study the effects of
glucose-6-phosphatase overexpression on rates of metabolic flux or on
control coefficients or response coefficients were determined relative
to AdCMV-
Gal-treated controls.

View larger version (18K):
[in a new window]
Fig. 2.
Glucose-6-phosphatase has a greater negative
control coefficient on glycogen synthesis than on glycolysis.
Hepatocytes were either untreated or treated with 5 titers of
AdCMV-G6Pase (G6Pase,
) or AdCMV-
Gal
(
-Gal,
) as in Fig. 1. They were incubated for 3 h in medium containing 25 mM glucose and either
[3-3H]glucose for determination of glycolysis
(A) or [U-14C]glucose for determination of
glycogen synthesis (B). Rates of glycolysis (detritiation of
[3-3H]glucose, nmol/3 h per mg) or glycogen synthesis
(incorporation of [U-14C]glucose into glycogen, nmol/3 h
per mg) are plotted against the glucose-6-phosphatase activity of the
untreated or AdCMV-G6Pase-treated cells. Cells treated with
AdCMV-
Gal are plotted on the same region of the x axis as
the corresponding titers of AdCMV-G6Pase-treated cells. Results are
means ± S.E. for six cultures. Insets show
representative double logarithmic plots from which the control
coefficients (CEJ) were
determined from the initial slope:
CG6PaseJGS =
0.45 ± 0.08;
CG6PaseJGly =
0.19 ± 0.04, n = 5.
0.45 ± 0.08) was 2-fold greater (p < 0.007)
than on glycolysis (CG6PaseJGly = -0.19 ± 0.04) indicating that a fractional change in
glucose-6-phosphatase (G6Pase) activity causes a 2-fold greater
fractional inhibition of glycogen synthesis compared with glycolysis at
25 mM glucose.

View larger version (20K):
[in a new window]
Fig. 3.
Glucose-6-phosphatase overexpression does not
affect glucokinase translocation in response to either glucose or
sorbitol. Hepatocytes treated with either AdCMV-G6Pase
(G6Pase,
) or with an equivalent titer of AdCMV-
Gal
(
-Gal,
) were incubated for 3 h in fresh medium
with the concentrations of glucose indicated (A and
C) or with 10 mM glucose and the concentrations
of sorbitol indicated (B and D). The medium was
supplemented with [2-3H]glucose for determination of
glucose phosphorylation (C and D) expressed as
nanomoles of 3H2O formed for 3 h per mg.
Glucokinase translocation expressed as free glucokinase percent of
total activity (A and B) was determined as
described under "Experimental Procedures." Results are means ± S.E. for six cultures. The activity of glucose-6-phosphatase in the
AdCMV-G6Pase-treated cells was 3.5 ± 0.9-fold higher than in
AdCMV-
Gal-treated cells.

View larger version (21K):
[in a new window]
Fig. 4.
Inhibition of glycolysis and glycogen
synthesis by glucose-6-phosphatase overexpression. Experimental
conditions were as in Fig. 3 except that incubations were supplemented
either with [3-3H]glucose for determination of glycolysis
(A and B) or with [U-14C]glucose
for determination of glycogen synthesis (C and D)
expressed as nmol/3 h per mg of protein. Results are means ± S.E.
for 6 (A and C) or 10 (B and
D) experiments. Glucose-6-phosphatase overexpression was
3.7 ± 0.7- and 3.3 ± 0.5-fold above
-galactosidase for
A, C, and B, D,
respectively. * p < 0.05; ** p < 0.005 AdCMV-G6Pase versus AdCMV-
Gal.
2-fold above endogenous
levels. The Taylor expansion is an approximation, based on a single
increment in enzyme expression and is a measure of the control
coefficient at the overexpressed rather than endogenous level (31).
Since control coefficients generally decrease with increasing enzyme
concentration, values obtained by this method may be lower than by
linear regression of double logarithmic plots.
0.29 and
0.35 and for glycolysis
(CG6PaseJGly) between
0.03 and
0.22. For the experiments at varying sorbitol concentrations,
CG6PaseJGly was
between
0.29 and
0.36 and
CG6PaseJGly between
0.11 and
0.13 (Table I). In most
cases the control coefficients for glycogen synthesis were higher than
for glycolysis by
2-fold. There was little or no variation in the
control coefficient on glycogen synthesis at varying substrate
conditions. Our results do not allow us to determine whether the
variation in control coefficient on glycolysis is significant.
Control coefficients of glucose-6-phosphatase on glycolysis and
glycogen synthesis
2-fold
above endogenous activity). Results are means ± S.E. for either
three (glucose) or five (sorbitol) experiments.
Gal-treated cells from the data in Fig. 4, A
and C. Response coefficients were determined from the double
logarithmic plots (log flux against log glucose) for individual
experiments. The response coefficients for glycolysis (RGlcJGly) were
similar for AdCMV-G6Pase-treated and AdCMV-
Gal-treated cells
(1.16 ± 0.07 and 1.18 ± 0.07, n = 6), and
the response coefficients for glycogen synthesis
(RGlcJGS) were lower
(p < 0.03) for AdCMV-G6Pase-treated than for
AdCMV-
Gal-treated cells (2.07 ± 0.08 and 2.26 ± 0.08, n = 6). Since glucose-6-phosphatase does not increase
the response coefficient to glucose of either glycolysis or glycogen
synthesis, this is further evidence against decreased binding of
glucokinase to its regulatory protein in response to a lowering of
hexose 6-phosphate by glucose-6-phosphatase overexpression.

View larger version (14K):
[in a new window]
Fig. 5.
Effects of adenovirus-mediated glucokinase
overexpression on glycolysis and glycogen synthesis at varying glucose
concentration. Hepatocytes were either untreated or treated with 5 titers of AdCMV-GKL to achieve varying degrees of glucokinase
overexpression. After 16 h culture, they were incubated for 3 h in medium containing the glucose concentrations (5-35
mM) indicated and either [3-3H]glucose for
determination of glycolysis (A) or
[U-14C]glucose for determination of glycogen synthesis
(B). Results are plotted as log flux (nmol/3 h per mg)
against log total glucokinase activity (milliunits/mg protein) and are
a representative experiment out of four. Control coefficients
determined from the individual experiments are summarized in Table
II.
Control coefficients of glucokinase on glycolysis and glycogen
synthesis
Effects of glucose-6-phosphatase overexpression on the control
coefficients of glucokinase on glycolysis and glycogen synthesis
Gal. They were then
incubated with varying sorbitol concentrations (5, 10, 50, 200 µM) for determination of glycolysis or glycogen synthesis
and glucokinase translocation. The control coefficients of glucokinase
on glycolysis (CGKJGly) or
glycogen synthesis (CGKJGS) were
determined from the slope of double logarithmic plots of flux against
free glucokinase activity (see Fig. 6). Results are means ± S.E.
for five cultures.

View larger version (16K):
[in a new window]
Fig. 6.
Effects of glucose-6-phosphatase
overexpression on the control coefficient of glucokinase on glycogen
synthesis. For experimental details see legends to Figs. 3 and 4.
Hepatocytes treated with either AdCMV-G6Pase (G6Pase,
,
) or AdCMV-
Gal (
-Gal,
) were incubated with the
concentrations of sorbitol shown in Fig. 3B in parallel
incubations without or with [U-14C]glucose for
determination of glucokinase translocation and glycogen synthesis,
respectively. Double logarithmic plots of glycogen synthesis (nmol/3 h
per mg) against free glucokinase activity (milliunits/mg protein) are
means of five experiments. Control coefficients determined from the
slopes of individual experiments are summarized in Table III.
Glucose-6-phosphatase activities were 2.0 ± 0.1-fold (
) or
4.6 ± 0.5-fold (
) above endogenous activity.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by Grant195002 from the Juvenile Diabetes Foundation International (to L. A.), Grant NIH1P50H2598801 from the National Institutes of Health (to C. B. N.), and a Canadian Medical Research Council Fellowship (to K. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Dept. of Diabetes, School of Clinical Medical Sciences, The Medical School, Newcastle upon Tyne NE2 4HH, UK. Tel.: 044 191 222 7033; Fax: 044 191 222 0723; E-mail loranne.agius@ncl.ac.uk.
| |
ABBREVIATIONS |
|---|
The abbreviation used is: Glc-6-Pase, glucose-6-phosphatase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Barzilai, N.,
and Rossetti, L.
(1993)
J. Biol. Chem.
268,
25019-25025 |
| 2. |
Mevorach, M.,
Giacca, A.,
Aharon, Y.,
Hawkins, M.,
Shamoon, H.,
and Rossetti, L.
(1998)
J. Clin. Invest.
102,
744-753 |
| 3. | Argaud, D., Zhang, Q., Pan, W., Maitra, S., Pilkis, S. J., and Lange, A. J. (1996) Diabetes 45, 1563-1571[Abstract] |
| 4. | Iyndejian, P. B. (1993) Biochem. J. 293, 1-13 |
| 5. |
Iynedjian, P. B.,
Jotterand, D.,
Nouspikel, T.,
Asfari, M.,
and Pilot, P. R.
(1989)
J. Biol. Chem.
264,
21824-21829 |
| 6. | Lange, A. J., Argaud, D., El-Maghrabi, M. R., Pan, W., Maitra, S. R, and Pilkis, S. J. (1994) Biochem. Biophys. Res. Commun. 201, 302-309[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Streeper, R. S.,
Svitek, C. A.,
Chapman, S.,
Greenbaum, L. E.,
Taub, T.,
and O'Brien, R. M.
(1997)
J. Biol. Chem.
272,
11698-11701 |
| 8. | Agius, L., and Peak, M. (1993) Biochem. J. 296, 785-796 |
| 9. | Agius, L., Peak, M., and Van Schaftingen, E (1995) Biochem. J. 309, 711-713 |
| 10. | Brown, K. S., Kalinowski, S. S., Megill, J. R., Durham, S. K., and Mookhtiar, K. A. (1997) Diabetes 46, 179-186[Abstract] |
| 11. | Van Schaftingen, E. (1989) Eur. J. Biochem. 179, 179-184[Medline] [Order article via Infotrieve] |
| 12. | Vandercammen, A., and Van Schaftingen, E. (1990) Eur. J. Biochem. 191, 483-489[Medline] [Order article via Infotrieve] |
| 13. | Vandercammen, A., and Van Schaftingen, E. (1991) Eur. J. Biochem. 200, 545-551[Medline] [Order article via Infotrieve] |
| 14. | Detheux, M., Vandercammen, A., and Van Schaftingen, E. (1991) Eur. J. Biochem. 200, 553-561[Medline] [Order article via Infotrieve] |
| 15. | Van Schaftingen, E., Veiga-da-Cunha, M., and Niculescu, L. (1997) Biochem. Soc. Trans. 25, 136-140[Medline] [Order article via Infotrieve] |
| 16. | Van Schaftingen, E. (1995) Biochem. J. 308, 23-29 |
| 17. | Niculescu, L., and Van Schaftingen, E. (1998) Diabetologia 41, 947-954[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Niculescu, L., Veiga-da-Cunha, M., and Van Schaftingen, E. (1997) Biochem. J. 321, 239-246 |
| 19. | Agius, L. (1997) Biochem. J. 325, 667-673 |
| 20. |
Seoane, J.,
Trinh, K.,
O'Doherty, R. M.,
Gomez-Foix, A. M.,
Lange, A. J.,
Newgard, C. B.,
and Guinovart, J. J.
(1997)
J. Biol. Chem.
272,
26972-26977 |
| 21. |
Agius, L.,
Peak, M.,
Newgard, C. B.,
Gomez-Foiz, A. M.,
and Guinovart, J. J.
(1996)
J. Biol. Chem.
271,
30479-30486 |
| 22. |
Trinh, K.,
Minassian, C.,
Lange, A. J.,
O'Doherty, R. M.,
and Newgard, C. B.
(1997)
J. Biol. Chem.
272,
24837-24834 |
| 23. |
Herz, J.,
and Gerard, R. D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
2812-2816 |
| 24. |
Becker, T. C.,
Noel, R. J.,
Johnson, J. H.,
Lynch, R. M.,
Hirose, H.,
Tokuyama, Y.,
Bell, G. I.,
and Newgard, C. B.
(1996)
J. Biol. Chem.
271,
390-394 |
| 25. | Agius, L., Peak, M., and Alberti, K. G. M. M. (1990) Biochem. J. 266, 91-102[Medline] [Order article via Infotrieve] |
| 26. | Clifton, P. M., Chang, K., and McKinnon, A. M. (1988) Anal. Biochem. 172, 165-168[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Alegre, M., Ciudad, C. J., Fillat, C., and Guinovart, J. J. (1988) Anal. Biochem. 173, 185-189[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Agius, L. (1998) Adv. Enzyme Regul. 38, 303-331[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Kacser, H., and Burns, J. A. (1979) Biochem. Soc. Trans. 7, 1149-1160[Medline] [Order article via Infotrieve] |
| 30. | Fell, D. A. (1992) Biochem. J. 286, 313-330 |
| 31. | Fell, D. (1997) in Understanding the Control of Metabolism (Snell, K., ed) , pp. 219-225, Portland Press Ltd., London |
| 32. | Hue, L. (1981) Adv. Enzymol. Relat. Areas Mol. Biol 52, 247-331[Medline] [Order article via Infotrieve] |
| 33. | Clark, D. G., Rognstad, R., and Katz, J. (1973) Biochem. Biophys. Res. Commun. 54, 1141-1148[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Seoane, J.,
Gomez-Foix, A. M.,
O'Doherty, R. M.,
Gomez-Ara, C.,
Newgard, C. B.,
and Guinovart, J. J.
(1996)
J. Biol. Chem.
271,
23756-23760 |
| 35. | Hers, H.-G., and Van Schaftingen, E. (1982) Biochem. J. 206, 1-12[Medline] [Order article via Infotrieve] |
| 36. | Hue, L., and Rider, M. H. (1987) Biochem. J. 245, 313-324[Medline] [Order article via Infotrieve] |
| 37. | Villar-Palasi, C., and Guinovart, J. J. (1997) FASEB J. 11, 544-558[Abstract] |
| 38. |
Massillon, D.,
Barzilai, N.,
Chen, W.,
Hu, M.,
and Rossetti, L.
(1996)
J. Biol. Chem.
271,
9871-9874 |
| 39. |
Argaud, D.,
Kirby, T. L.,
Newgard, C. B.,
and Lange, A. J.
(1997)
J. Biol. Chem.
272,
12854-12861 |
| 40. | Chatelain, F., Pegorier, J. P., Minassian, C., Bruni, N., Tarpin, S., Girard, J., and Mithieux, G. (1998) Diabetes 47, 882-889[Abstract] |
| 41. |
Scott, D. K.,
O'Doherty, R. M.,
Stafford, J. M.,
Newgard, C. B.,
and Granner, D. K.
(1998)
J. Biol. Chem.
273,
24145-24151 |
| 42. |
Trinh, K. Y.,
O'Doherty, R. M.,
Anderson, P.,
Lange, A. J.,
and Newgard, C. B.
(1998)
J. Biol. Chem.
273,
31615-31620 |
| 43. | Groen, A. K., van Roermund, C. W. T., Vervoorn, R. C., and Tager, J. M. (1986) Biochem. J. 237, 379-389[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
C. Arden, A. Trainer, N. de la Iglesia, K. T. Scougall, A. L. Gloyn, A. J. Lange, J. A.M. Shaw, F. M. Matschinsky, and L. Agius Cell Biology Assessment of Glucokinase Mutations V62M and G72R in Pancreatic {beta}-Cells: Evidence for Cellular Instability of Catalytic Activity Diabetes, July 1, 2007; 56(7): 1773 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Pedersen, P. Zhang, C. Doumen, M. Charbonnet, D. Lu, C. B. Newgard, J. W. Haycock, A. J. Lange, and D. K. Scott The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E788 - E801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Soengas, S. Polakof, X. Chen, S. Sangiao-Alvarellos, and T. W. Moon Glucokinase and hexokinase expression and activities in rainbow trout tissues: changes with food deprivation and refeeding Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R810 - R821. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sezgin, D. D. Duvernell, L. M. Matzkin, Y. Duan, C.-T. Zhu, B. C. Verrelli, and W. F. Eanes Single-Locus Latitudinal Clines and Their Relationship to Temperate Adaptation in Metabolic Genes and Derived Alleles in Drosophila melan |